Update in the Management of Sickle Cell Disease

In this episode, Nirmish Shah, MD, speaks about updates in the management of sickle cell disease (SCD), including the clinical utility, side effects, and appropriate monitoring of crizanlizumab, voxelotor, and L-glutamine for pediatric patients with SCD. Dr Shah also discusses the appropriate adjuvant agents for 3 pediatric patients in various clinical scenarios and reviews preliminary data from ongoing clinical trials in SCD.